CMPI.org

In the News

Systemic Practices in Indiana’s Non-Profit Hospitals That Inflate Health Care Costs

08/05/2025 12:00 AM | CMPI

New Report on New York State Not-for-Profit Hospitals

07/31/2025 12:00 AM | CMPI

FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding Puts Patients at Risk

07/21/2025 12:00 AM | CMPI

Unmasking the Real Cost Drivers in U.S. Healthcare: A Critical Examination of Hospital Pricing and Policy Reform

06/23/2025 12:00 AM | CMPI

Countries Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation - What Can the US Do to Change That?

05/09/2025 12:00 AM | RCJ

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

10/17/2024 12:00 AM | STAT

White Paper: Expanding Access to Pneumonia Vaccines — A Vital Public Health Measure

10/08/2024 12:00 AM | CMPI

07/18/2024 12:00 AM | CMPI

Tort bar’s newest collateral damage: Preterm babies

07/02/2024 12:00 AM | The Washington Times

New CMPI Book: And Nothing But the Truth

06/11/2024 12:00 AM | CMPI

Product Failure Is Not Process Failure

03/21/2024 12:00 AM | RealClearHealth

The Future of U.S. Biopharmaceutical Innovation and Supply Chain Security Lies in the Abraham Accords Region

03/07/2024 12:00 AM | RealClearHealth

Sorry, but the ‘drugs from Canada’ don’t work

01/05/2024 12:00 AM | New York Post

Center for Medicine in the Public Interest Statement on ITC TRIPS Waiver Report

10/18/2023 12:00 AM | CMPI

When It Comes to FDA Communications

10/17/2023 12:00 AM | RealClearHealth

Drug shortages reaching record levels

09/19/2023 12:00 AM | Scripps News

Richard Bagger Joins CMPI Board of Directors

09/05/2023 12:00 AM | CMPI

Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional

06/14/2023 12:00 AM | The Washington Times

Reality-Based Healthcare Reform

06/13/2023 12:00 AM | FDLI

CMS comments on IRA Implementation

05/15/2023 12:00 AM | CMPI

Previous
1
2
3
4
5
...
12
Next

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

CMPI
02/03/2026 12:00 AM

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more

Read all News